Performing comparative peptidomics analyses of Salmonella from different growth conditions.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 20013197)

Published in Methods Mol Biol on January 01, 2010

Authors

Joshua N Adkins1, Heather Mottaz, Thomas O Metz, Charles Ansong, Nathan P Manes, Richard D Smith, Fred Heffron

Author Affiliations

1: Pacific Northwest National Laboratory, Fundamental and Computational Sciences Directorate, Richland, WA, USA.

Articles by these authors

Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome. J Virol (2004) 4.30

Human Proteinpedia enables sharing of human protein data. Nat Biotechnol (2008) 4.21

Probability-based evaluation of peptide and protein identifications from tandem mass spectrometry and SEQUEST analysis: the human proteome. J Proteome Res (2005) 4.13

Advances in proteomics data analysis and display using an accurate mass and time tag approach. Mass Spectrom Rev (2006) 3.80

Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry. Mol Cell Proteomics (2002) 3.57

DAnTE: a statistical tool for quantitative analysis of -omics data. Bioinformatics (2008) 3.51

Comparative analysis of proteome and transcriptome variation in mouse. PLoS Genet (2011) 3.23

How much will Herceptin really cost? BMJ (2006) 3.23

Chemically etched open tubular and monolithic emitters for nanoelectrospray ionization mass spectrometry. Anal Chem (2006) 3.22

VIPER: an advanced software package to support high-throughput LC-MS peptide identification. Bioinformatics (2007) 3.15

Global analysis of the Deinococcus radiodurans proteome by using accurate mass tags. Proc Natl Acad Sci U S A (2002) 3.15

Normalization approaches for removing systematic biases associated with mass spectrometry and label-free proteomics. J Proteome Res (2006) 3.10

High-sensitivity ion mobility spectrometry/mass spectrometry using electrodynamic ion funnel interfaces. Anal Chem (2005) 2.99

An IMS-IMS analogue of MS-MS. Anal Chem (2006) 2.68

Whole proteome analysis of post-translational modifications: applications of mass-spectrometry for proteogenomic annotation. Genome Res (2007) 2.67

Decon2LS: An open-source software package for automated processing and visualization of high resolution mass spectrometry data. BMC Bioinformatics (2009) 2.65

sciS, an icmF homolog in Salmonella enterica serovar Typhimurium, limits intracellular replication and decreases virulence. Infect Immun (2005) 2.64

Quantitative proteome analysis of human plasma following in vivo lipopolysaccharide administration using 16O/18O labeling and the accurate mass and time tag approach. Mol Cell Proteomics (2005) 2.50

Temporal proteome and lipidome profiles reveal hepatitis C virus-associated reprogramming of hepatocellular metabolism and bioenergetics. PLoS Pathog (2010) 2.48

Reversed-phase chromatography with multiple fraction concatenation strategy for proteome profiling of human MCF10A cells. Proteomics (2011) 2.44

Omic data from evolved E. coli are consistent with computed optimal growth from genome-scale models. Mol Syst Biol (2010) 2.41

Accurate prediction of secreted substrates and identification of a conserved putative secretion signal for type III secretion systems. PLoS Pathog (2009) 2.41

Binding MOAD (Mother Of All Databases). Proteins (2005) 2.40

DeconMSn: a software tool for accurate parent ion monoisotopic mass determination for tandem mass spectra. Bioinformatics (2008) 2.38

Fully automated four-column capillary LC-MS system for maximizing throughput in proteomic analyses. Anal Chem (2007) 2.38

Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry. J Proteome Res (2005) 2.35

Integrative analysis of the mitochondrial proteome in yeast. PLoS Biol (2004) 2.31

Statistical characterization of the charge state and residue dependence of low-energy CID peptide dissociation patterns. Anal Chem (2005) 2.29

High dynamic range characterization of the trauma patient plasma proteome. Mol Cell Proteomics (2006) 2.25

High-resolution field asymmetric waveform ion mobility spectrometry using new planar geometry analyzers. Anal Chem (2006) 2.19

Toward plasma proteome profiling with ion mobility-mass spectrometry. J Proteome Res (2006) 2.18

Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications. Mol Cell Proteomics (2006) 2.14

Transport functions dominate the SAR11 metaproteome at low-nutrient extremes in the Sargasso Sea. ISME J (2008) 2.11

Evaluation of multiprotein immunoaffinity subtraction for plasma proteomics and candidate biomarker discovery using mass spectrometry. Mol Cell Proteomics (2006) 2.11

Enhanced detection of low abundance human plasma proteins using a tandem IgY12-SuperMix immunoaffinity separation strategy. Mol Cell Proteomics (2008) 2.08

A statistical framework for protein quantitation in bottom-up MS-based proteomics. Bioinformatics (2009) 2.07

Development and evaluation of a micro- and nanoscale proteomic sample preparation method. J Proteome Res (2005) 2.06

The genome of Cyanothece 51142, a unicellular diazotrophic cyanobacterium important in the marine nitrogen cycle. Proc Natl Acad Sci U S A (2008) 2.05

Ionization and transmission efficiency in an electrospray ionization-mass spectrometry interface. J Am Soc Mass Spectrom (2007) 2.03

Fundamentals of traveling wave ion mobility spectrometry. Anal Chem (2008) 2.02

Clinical microfluidics for neutrophil genomics and proteomics. Nat Med (2010) 2.02

Use of artificial neural networks for the accurate prediction of peptide liquid chromatography elution times in proteome analyses. Anal Chem (2003) 2.00

Ultra-high-efficiency strong cation exchange LC/RPLC/MS/MS for high dynamic range characterization of the human plasma proteome. Anal Chem (2004) 2.00

High-throughput comparative proteome analysis using a quantitative cysteinyl-peptide enrichment technology. Anal Chem (2004) 1.99

Binding MOAD, a high-quality protein-ligand database. Nucleic Acids Res (2007) 1.99

Clustering millions of tandem mass spectra. J Proteome Res (2007) 1.98

Head-to-head comparison of serum fractionation techniques. J Proteome Res (2007) 1.98

Utilizing human blood plasma for proteomic biomarker discovery. J Proteome Res (2005) 1.96

Spectral archives: extending spectral libraries to analyze both identified and unidentified spectra. Nat Methods (2011) 1.95

Comparative proteome analyses of human plasma following in vivo lipopolysaccharide administration using multidimensional separations coupled with tandem mass spectrometry. Proteomics (2005) 1.94

High throughput quantitative analysis of serum proteins using glycopeptide capture and liquid chromatography mass spectrometry. Mol Cell Proteomics (2004) 1.94

Global profiling of Shewanella oneidensis MR-1: expression of hypothetical genes and improved functional annotations. Proc Natl Acad Sci U S A (2005) 1.93

Ion mobility spectrometry-mass spectrometry performance using electrodynamic ion funnels and elevated drift gas pressures. J Am Soc Mass Spectrom (2007) 1.93

Characterization of the mouse brain proteome using global proteomic analysis complemented with cysteinyl-peptide enrichment. J Proteome Res (2006) 1.93

Proteomics by FTICR mass spectrometry: top down and bottom up. Mass Spectrom Rev (2005) 1.91

Ion funnel trap interface for orthogonal time-of-flight mass spectrometry. Anal Chem (2007) 1.88

High-efficiency nanoscale liquid chromatography coupled on-line with mass spectrometry using nanoelectrospray ionization for proteomics. Anal Chem (2002) 1.88

Automated 20 kpsi RPLC-MS and MS/MS with chromatographic peak capacities of 1000-1500 and capabilities in proteomics and metabolomics. Anal Chem (2005) 1.87

Precautionary behavior in response to perceived threat of pandemic influenza. Emerg Infect Dis (2007) 1.84

Robust algorithm for alignment of liquid chromatography-mass spectrometry analyses in an accurate mass and time tag data analysis pipeline. Anal Chem (2006) 1.83

Analysis of the Salmonella typhimurium proteome through environmental response toward infectious conditions. Mol Cell Proteomics (2006) 1.82

Proteome and computational analyses reveal new insights into the mechanisms of hepatitis C virus-mediated liver disease posttransplantation. Hepatology (2012) 1.82

Improving mass spectrometer sensitivity using a high-pressure electrodynamic ion funnel interface. J Am Soc Mass Spectrom (2006) 1.80

Proteomic analyses using an accurate mass and time tag strategy. Biotechniques (2004) 1.80

PRISM: a data management system for high-throughput proteomics. Proteomics (2006) 1.80

Does trypsin cut before proline? J Proteome Res (2007) 1.79

Enhanced ion utilization efficiency using an electrodynamic ion funnel trap as an injection mechanism for ion mobility spectrometry. Anal Chem (2008) 1.79

Tandem mass spectrometry identifies many mouse brain O-GlcNAcylated proteins including EGF domain-specific O-GlcNAc transferase targets. Proc Natl Acad Sci U S A (2012) 1.75

Attenuated Francisella novicida transposon mutants protect mice against wild-type challenge. Infect Immun (2006) 1.73

Direct mass spectrometric analysis of intact proteins of the yeast large ribosomal subunit using capillary LC/FTICR. Proc Natl Acad Sci U S A (2002) 1.72

Comparative proteogenomics: combining mass spectrometry and comparative genomics to analyze multiple genomes. Genome Res (2008) 1.68

An automated high performance capillary liquid chromatography-Fourier transform ion cyclotron resonance mass spectrometer for high-throughput proteomics. J Am Soc Mass Spectrom (2004) 1.68

Home-based medication review in older people: is it cost effective? Pharmacoeconomics (2007) 1.67

Ultrasensitive proteomics using high-efficiency on-line micro-SPE-nanoLC-nanoESI MS and MS/MS. Anal Chem (2004) 1.66

Charge competition and the linear dynamic range of detection in electrospray ionization mass spectrometry. J Am Soc Mass Spectrom (2004) 1.66

Disclosure of genetic tests for health insurance: is it ethical not to? Lancet (2004) 1.65

Two-dimensional gas-phase separations coupled to mass spectrometry for analysis of complex mixtures. Anal Chem (2005) 1.65

Assessing quality of life in the elderly: a direct comparison of the EQ-5D and AQoL. Health Econ (2004) 1.64

Proteogenomics: needs and roles to be filled by proteomics in genome annotation. Brief Funct Genomic Proteomic (2008) 1.63

CSAR benchmark exercise of 2010: selection of the protein-ligand complexes. J Chem Inf Model (2011) 1.61

MASIC: a software program for fast quantitation and flexible visualization of chromatographic profiles from detected LC-MS(/MS) features. Comput Biol Chem (2008) 1.61

Proteome analyses using accurate mass and elution time peptide tags with capillary LC time-of-flight mass spectrometry. J Am Soc Mass Spectrom (2003) 1.59

Improved peptide elution time prediction for reversed-phase liquid chromatography-MS by incorporating peptide sequence information. Anal Chem (2006) 1.59

Coordinated regulation of virulence during systemic infection of Salmonella enterica serovar Typhimurium. PLoS Pathog (2009) 1.58

In silico method for modelling metabolism and gene product expression at genome scale. Nat Commun (2012) 1.58

Global systems-level analysis of Hfq and SmpB deletion mutants in Salmonella: implications for virulence and global protein translation. PLoS One (2009) 1.58

Identification of new secreted effectors in Salmonella enterica serovar Typhimurium. Infect Immun (2005) 1.58

Paying for statins. BMJ (2004) 1.57

Application of peptide LC retention time information in a discriminant function for peptide identification by tandem mass spectrometry. J Proteome Res (2004) 1.56

Proteomic analysis of Salmonella enterica serovar typhimurium isolated from RAW 264.7 macrophages: identification of a novel protein that contributes to the replication of serovar typhimurium inside macrophages. J Biol Chem (2006) 1.55

Establishing the proteome of normal human cerebrospinal fluid. PLoS One (2010) 1.53